Its APIs include Apixaban, Edoxaban ... Its home health products include Dr. Morepen 49W Room Air Purifier with HEPA Filter, Dr. Morepen VP06 Breathe Free Vaporizer, Dr. Morepen CN06 Compressor ...

Morepen Laboratories Limited has received approval from the Center for Drug Evaluation (CDE) of China’s National Medical Products Administration (NMPA) for its anti-allergy API, Loratadine.

Dr. Michael “Robby” Robinavitch is the doctor you want standing over you in an emergency situation – calm-mannered, determined, with soulful eyes and a good looking beard. He may be a ...

The aim of the API-CAT trial was to assess whether the lower dose of apixaban was comparable to the full dose in preventing VTE recurrence in patients with active cancer who had completed at least ...

Patients were randomly assigned to be treated with either 5 mg (2.5mg twice daily; the reduced-dose group) or 10 mg (5 mg twice daily; the full-dose group) of apixaban for an additional 12 months.

Sandra Lee mentors young dermatologists while treating some of the “craziest things” in PEOPLE's exclusive look at her new show "Dr. Pimple Popper: Breaking Out" Jason Elias/Lifetime Dr ...

Patients with active cancer who developed a blood clot, or venous thromboembolism (VTE), and were treated with blood-thinning medication for at least six months, followed by an additional 12 months of ...

CHICAGO — Extended therapy with reduced-dose apixaban is just as effective as the high dose in preventing recurrent venous thromboembolism (VTE) in patients with active cancer who completed at ...

Active pharmaceutical ingredient maker Morepen Laboratories has received approval for anti-allergy API Loratadine from the Center for Drug Evaluation of China’s National Medical Products ...

Morepen Laboratories Ltd. announced April 1 that it has received a green signal from China’s Center for Drug Evaluation (CDE) at the National Medical Products Administration (NMPA) for the ...